DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Rating of “Moderate Buy” from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has been assigned an average recommendation of “Moderate Buy” from the eleven research firms that are presently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $35.89.

A number of research analysts have weighed in on XRAY shares. Needham & Company LLC reduced their price target on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research note on Friday. StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday. Piper Sandler reissued a “neutral” rating and issued a $32.00 price target (down from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday. SVB Leerink began coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective for the company. Finally, Leerink Partnrs reissued an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th.

DENTSPLY SIRONA Trading Down 0.3 %

DENTSPLY SIRONA stock opened at $28.29 on Friday. The stock has a market cap of $5.87 billion, a PE ratio of -64.29, a P/E/G ratio of 1.15 and a beta of 1.00. The company has a current ratio of 1.43, a quick ratio of 0.95 and a debt-to-equity ratio of 0.54. The stock has a 50-day moving average price of $32.13 and a 200 day moving average price of $32.71. DENTSPLY SIRONA has a 52 week low of $26.27 and a 52 week high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts’ consensus estimates of $0.42. The business had revenue of $953.00 million during the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.39 earnings per share. Equities research analysts predict that DENTSPLY SIRONA will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were issued a dividend of $0.16 per share. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a dividend yield of 2.26%. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Parkside Financial Bank & Trust lifted its position in shares of DENTSPLY SIRONA by 33.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 292 shares in the last quarter. Beach Investment Counsel Inc. PA boosted its position in DENTSPLY SIRONA by 1.4% in the 4th quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock valued at $787,000 after buying an additional 306 shares during the last quarter. Wahed Invest LLC grew its stake in shares of DENTSPLY SIRONA by 9.3% during the fourth quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier’s stock valued at $128,000 after acquiring an additional 306 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. increased its position in shares of DENTSPLY SIRONA by 5.4% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,950 shares of the medical instruments supplier’s stock worth $237,000 after acquiring an additional 359 shares during the last quarter. Finally, VisionPoint Advisory Group LLC lifted its stake in shares of DENTSPLY SIRONA by 104.2% in the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 395 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.